EVUSHELD recall in Canada: May not be effective against COVID-19 variants
In plain language
This recall involves EVUSHELD (tixagevimab and cilgavimab for injection) sold in Canada. It's being recalled because it may not be effective against certain SARS-CoV-2 Omicron subvariants. Stop using the product and follow the return/repair steps in the official notice.
What to do
- Stop using the product immediately.
- Consult your healthcare professional for advice.
- Seek medical advice if COVID-19 symptoms occur, persist, or worsen.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
EVUSHELD (150 mg/1.5 mL tixagevimab; 150 mg/1.5 mL cilgavimab) co-packaged solution for intramuscular injection
Model: DIN: 02526271
Why this matters
Risk of prophylaxis or treatment failure
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: DIN: 02526271
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Risk of prophylaxis or treatment failure
What should consumers do?
Stop using the product immediately. Consult your healthcare professional for advice. Seek medical advice if COVID-19 symptoms occur, persist, or worsen.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Risk of prophylaxis or treatment failure
When was this product recalled?
This product was recalled on January 17, 2023.
Is the EVUSHELD brand affected by this recall?
Yes, EVUSHELD products are affected by this recall. This recall involves EVUSHELD (tixagevimab and cilgavimab for injection) sold in Canada. It's being recalled because it may not be effective against certain SARS-CoV-2 Omicron subvariants. Stop using the product and follow the return/repair steps in the official notice.